Infection of Zebrafish Larvae with Aspergillus Spores for Analysis of Host-Pathogen Interactions
May 16th, 2020
5.2K views
This protocol describes an Aspergillus infection model in zebrafish larvae. Aspergillus spores are microinjected into the hindbrain of larvae, and chemical treatment is used to induce immunosuppression. Infection progression is monitored via a daily imaging setup to monitor fungal growth and immune responses as well as enumeration of live spores by colony forming unit plating.
Overview
This protocol describes a model for studying Aspergillus infection in zebrafish larvae, allowing for real-time visualization of immune responses. The method involves microinjecting spores into the hindbrain and monitoring infection progression through imaging.
Key Study Components
Area of Science
- Neuroscience
- Immunology
- Microbiology
Background
- Aspergillus fumigatus is an opportunistic pathogen affecting immunocompromised individuals.
- Zebrafish larvae provide a transparent model for observing immune interactions.
- Microinjection techniques are critical for successful experimental outcomes.
- Monitoring infection can lead to insights into therapeutic targets for invasive aspergillosis.
Purpose of Study
- To investigate innate immune responses to Aspergillus in a live host.
- To visualize immune cell interactions with pathogens over time.
- To develop a reliable method for studying fungal infections in zebrafish.
Methods Used
- Microinjection of Aspergillus spores into the hindbrain of zebrafish larvae.
- Use of imaging techniques to monitor infection progression.
- Enumeration of live spores through colony forming unit plating.
- Application of chemical treatments to induce immunosuppression.
Main Results
- Successful visualization of immune responses to fungal infection.
- Establishment of a reproducible microinjection technique.
- Identification of infection progression patterns in live larvae.
- Potential implications for therapeutic target discovery in invasive aspergillosis.
Conclusions
- The zebrafish model is effective for studying Aspergillus infections.
- Real-time imaging provides valuable insights into immune responses.
- This protocol can aid in the development of treatments for fungal infections.
Frequently Asked Questions
What is the significance of using zebrafish larvae in this study?
Zebrafish larvae allow for real-time visualization of immune responses due to their transparency, making them ideal for studying pathogen interactions.
How are the Aspergillus spores injected into the larvae?
Spores are microinjected into the hindbrain using a specialized microinjection setup, ensuring precise delivery.
What are the risks associated with the microinjection technique?
There is a risk of skin puncture with the needle, so researchers must handle the equipment carefully and wear gloves.
How is infection progression monitored?
Infection progression is monitored through daily imaging setups that track fungal growth and immune responses.
What are the potential applications of this research?
Findings may lead to the discovery of new therapeutic targets for treating invasive aspergillosis in immunocompromised patients.
Executive Industry Relevance
This zebrafish larval model enables real-time visualization of host-pathogen interactions, supporting mechanistic de-risking of antifungal target validation. By quantifying spore persistence and immune cell dynamics, it provides predictive confidence in early discovery of therapeutics for invasive aspergillosis. The model’s optical clarity and genetic tractability facilitate translational continuity from discovery to preclinical evaluation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of host factors contributing to infection susceptibility and survival rates in immunocompromised hosts.
- Operational Value: Supports functional validation of innate immune pathways through live imaging of macrophage and neutrophil recruitment.
- Predictive Value: Allows assessment of therapeutic impact on fungal burden and dissemination patterns over time.
Screening & Assay Development
- Scientific Value: Provides quantitative CFU enumeration to measure spore clearance and persistence across experimental conditions.
- Operational Value: Enables standardized infection readouts via homogenization and plating for reproducible antifungal screening.
- Assay Readiness: Supports daily live imaging setups to monitor germination, phagocyte clustering, and fungal dissemination.
Translational & Preclinical Research
- Scientific Value: Facilitates evaluation of immunosuppressed models to mimic clinical conditions in immunocompromised patients.
- Operational Value: Enables testing of chemical inhibitors in larval water to assess drug efficacy on infection progression.
- Translational Continuity: Supports extrapolation of immune response patterns to inform preclinical target selection.
Pipeline & Workflow Integration
The method integrates into early discovery workflows by providing live-cell imaging and quantitative outputs for hypothesis testing in antifungal development.
- Discovery Biology: Supports mechanistic interrogation of host-pathogen interactions through visualization of immune cell clustering and fungal germination.
- Screening: Enables antifungal compound evaluation via CFU-based quantification of spore survival and clearance kinetics.
- Analytics: Generates quantitative dependent variable measurements (spore counts, survival rates, immune cell recruitment) for cross-condition comparison.
- Translational Research: Connects immune response dynamics in larvae to potential biomarker alignment in human infection models.
- Enterprise Reuse: Establishes a reusable platform for testing multiple Aspergillus strains and host genetic backgrounds.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in antifungal target validation through direct observation of immune effector functions.
- Operational Value: Standardizes infection modeling via reproducible microinjection and environmental control of immunosuppression.
- Strategic Value: Improves go/no-go decisions by linking immune modulation to survival outcomes in infected larvae.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on impact on fungal persistence and dissemination.
Implementation Considerations
- Requires expertise in zebrafish handling, microinjection, and confocal imaging for consistent results.
- Dependent on pressure injection setup, micropipettes, and sterile spore suspension preparation.
- Necessitates standardization of larval staging, anesthesia, and injection plate preparation across teams.
- Requires adaptation considerations when applying to different Aspergillus strains or mutant zebrafish lines.
- Practical limitations include technical difficulty of microinjection and variability in spore suspension viability.
Biopharma FAQs
Why does CFU enumeration matter for target validation in this model?
CFU enumeration quantifies spore persistence and clearance over time, enabling measurement of antifungal efficacy and host defense mechanisms. This provides a dependent variable for evaluating therapeutic impact on fungal burden.
How does hindbrain ventricle injection support independent variable isolation in discovery?
Microinjection into the hindbrain ventricle delivers a controlled spore dose, isolating the infection variable while minimizing tissue damage. This enables precise testing of host or pathogen factors affecting progression.
What do daily live imaging setups enable for quantitative dependent variable measurement?
Daily imaging tracks fungal germination, immune cell recruitment, and dissemination, generating time-resolved data on infection progression. These outputs allow comparison of dynamics across genetic or treatment conditions.
Why are replication requirements important for cross-functional collaboration in this model?
Replication ensures consistent spore delivery and survival rates, which is essential for reliable comparison of antifungal or genetic interventions. Standardized protocols support data sharing between discovery and preclinical teams.
What statistical analysis capabilities are required before implementing this assay?
Teams require the ability to normalize spore counts to initial inoculum and compare survival or clearance across replicates. Statistical evaluation of immune cell clustering and dissemination frequency is needed to assess significance.
Chapters in this video
0:04
Introduction
0:57
Zebrafish Larva Hindbrain Ventricle Microinjection
4:21
Establishment of Injected and Viable Spore Numbers
5:22
Drug Treatment of Larvae and Survival Analysis
5:53
Zebrafish Wounding and Entrapment Device for Growth and Imaging
7:23
Results: Infection Outcome of Aspergillus Spores Microinjected into Zebrafish Larvae
9:07
Conclusion
